About this trial
This clinical trial will evaluate the effectiveness of eggshell-derived calcium hydroxyapatite compared to calcium hydroxide as indirect pulp capping agent in permanent teeth. A total of 54 teeth from healthy individuals aged 18 to 40 years will be randomly allocated into two groups:
Group A (experimental) treated with eggshell-derived calcium hydroxyapatite. Group B (control) treated with calcium hydroxide.
After caries removal the assigned pulp capping agent will be applied, and the teeth will be restored. Clinical and radiographic evaluations will be performed at 1 and 3 months to assess pulp vitality, symptom-free status, and periapical health.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Teeth with symptoms of reversible pulpitis.
Teeth that show positive response on electric pulp testing (EPT).
Teeth with caries penetrating up to three-quarters (¾) of dentine without pulp involvement.
Healthy cooperative patients of both sexes between 18 to 40 years of age.
Disqualifiers
Necrosed Teeth with radiolucency in the periapical and furcation regions.
Tooth with internal and external root resorption.
Periodontally compromised tooth. (BPE score 3 and above)
Physically and mentally handicapped patients. (ASA score 3 and above)
Trial design
Parallel
Treatments tested in this trial
eggshell-derived calcium hydroxyapatite
Biological/Vaccineeggshell-derived calcium hydroxyapatite will be placed as an indirect pulp capping material after chemo-mechanical caries removal and before final restoration with glass ionomer cement and composite resin.
Calcium hydroxide
Biological/VaccineCalcium hydroxide will be placed as an indirect pulp capping material after chemo-mechanical caries removal and before final restoration with glass ionomer cement and composite resin.
Treatment groups
Trial outcomes
Primary outcomes
clinical symptoms (pain on percussion, tooth mobility) and radiographic evaluation
Evaluates absence of pain and pathological mobility, Measures dentine bridge thickness and absence of periapical pathology.
Secondary outcomes
restoration success, post operative sensitivity
Records patient-reported sensitivity and discomfort
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: